3.4.24.75: lysostaphin
This is an abbreviated version!
For detailed information about lysostaphin, go to the full flat file.
Word Map on EC 3.4.24.75
-
3.4.24.75
-
staphylococci
-
methicillin-resistant
-
vancomycin
-
simulans
-
bactericidal
-
pentaglycine
-
bacteriolytic
-
methicillin
-
epidermidis
-
mastitis
-
antistaphylococcal
-
cross-bridge
-
bacteriocins
-
staphylolyticus
-
medicine
-
autolysins
-
oxacillin
-
endolysins
-
interpeptide
-
teichoic
-
biovar
-
intramammary
-
coagulase-negative
-
muropeptide
-
teicoplanin
-
methicillin-sensitive
-
cowan
-
micrococci
-
murein
-
haemolyticus
-
coagulase
-
daptomycin
-
mutanolysine
-
diagnostics
-
pharmacology
-
food industry
-
analysis
- 3.4.24.75
-
staphylococci
-
methicillin-resistant
- vancomycin
- simulans
-
bactericidal
- pentaglycine
-
bacteriolytic
- methicillin
- epidermidis
- mastitis
-
antistaphylococcal
-
cross-bridge
-
bacteriocins
- staphylolyticus
- medicine
- autolysins
- oxacillin
- endolysins
-
interpeptide
-
teichoic
-
biovar
-
intramammary
-
coagulase-negative
-
muropeptide
- teicoplanin
-
methicillin-sensitive
-
cowan
-
micrococci
- murein
- haemolyticus
- coagulase
-
daptomycin
-
mutanolysine
- diagnostics
- pharmacology
- food industry
- analysis
Reaction
Hydrolysis of the -Gly-/-Gly- bond in the pentaglycine inter-peptide link joining staphylococcal cell wall peptidoglycans =
Synonyms
ALE-1, BSYX-L210, Glycyl-glycine endopeptidase, Glycylglycine endopeptidase, Lspn, Lss, Lst, LYS, lysostaphin, Lysostaphin endopeptidase, LytU, More, peptidoglycan endopeptidase, r-Lys, r-lysostaphin, sa0205, SH3b, Staphylococcus aureus-specific cell wall endopeptidase lysostaphin
ECTree
3.4.24.75 lysostaphinAdvanced search results
results (
results (General Stability
General Stability on EC 3.4.24.75 - lysostaphin
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
top
GENERAL STABILITY 
ORGANISM
UNIPROT
LITERATURE
lysostaphin degrades Staphylococcus aureus cell walls inefficiently in low conductivity buffers (10-50 mS/cm)
lysostaphin fused it with an anti-parallel alpha-helical dimerization domain has a more favorable pharmacokinetic profile with increased terminal half-life compared to monomeric lysostaphin. However, the staphylolytic activity of dimerized lysostaphin is decreased.
lysostaphin is relatively stable when conjugated with polyethylene glycol and it maintains its activity in human serum
relatively unaffected by salt concentrations between 200 and 500 mM, LysK has a higher specific activity than lysostaphin at NaCl concentrations higher than 150 mM (turbidity reduction assay)
-
